Clinical Trials
2 trialsNCT01630018 2016-09-22
Belotecan Versus Topotecan for Recurrent Ovarian Cancer: A Randomized, Open-label, Parallel-group Phase IIb Trial
Chong Kun Dang Pharmaceutical
Phase 2 Completed
NCT00430144 2012-04-26
Belotecan (CKD-602) in Recurrent or Progressive Carcinoma of Uterine Cervix
National Cancer Center, Korea
Phase 2 Completed